Genetic Analysis AS (FRA:8V8) Change In Receivables : €-0.21 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Genetic Analysis AS Change In Receivables?

Genetic Analysis AS's change in receivables for the quarter that ended in Dec. 2023 was €0.09 Mil. It means Genetic Analysis AS's Accounts Receivable declined by €0.09 Mil from Sep. 2023 to Dec. 2023 .

Genetic Analysis AS's change in receivables for the fiscal year that ended in Dec. 2023 was €0.06 Mil. It means Genetic Analysis AS's Accounts Receivable declined by €0.06 Mil from Dec. 2022 to Dec. 2023 .

Genetic Analysis AS's Accounts Receivable for the quarter that ended in Dec. 2023 was €0.17 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Genetic Analysis AS's Days Sales Outstanding for the three months ended in Dec. 2023 was 45.63.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Genetic Analysis AS's liquidation value for the three months ended in Dec. 2023 was €-0.35 Mil.

Genetic Analysis AS Change In Receivables Historical Data

The historical data trend for Genetic Analysis AS's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Analysis AS Change In Receivables Chart

Genetic Analysis AS Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

-0.61

0.60

-0.02

-0.15

0.06

Genetic Analysis AS Quarterly Data
	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Receivables	Get a 7-Day Free Trial										-0.13	0.01	-0.27	-0.04	0.09

Genetic Analysis AS Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.21 Mil.

Genetic Analysis AS (FRA:8V8) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Genetic Analysis AS's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.165	/	0.33	*	91
=	45.63

2. In Ben Graham's calculation of liquidation value, Genetic Analysis AS's accounts receivable are only considered to be worth 75% of book value:

Genetic Analysis AS's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1.328	-	1.868	+	0.75 * 0.165	+	0.5 * 0.134
=	-0.35

Genetic Analysis AS Change In Receivables Related Terms

Thank you for viewing the detailed overview of Genetic Analysis AS's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetic Analysis AS (FRA:8V8) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Analysis AS (FRA:8V8) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

GEAN:Sweden

Address

Kabelgata 8, Oslo, NOR, 0580

Website

https://www.genetic-analysis.com

Genetic Analysis AS is a research-driven diagnostic company dedicated to delivering innovative diagnostic solutions to the growing human microbiota market. It is providing a CE-marked gut microbiota analysis for testing bacterial imbalance in IBS and IBD patients.

Genetic Analysis AS (FRA:8V8) Headlines

No Headlines